EUROFINS SCIENT Inventory 2018-2023 | ERFSF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

EUROFINS SCIENT inventory from 2018 to 2023. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

EUROFINS SCIENT inventory from 2018 to 2023. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$124.8B
Cencora (COR)	$44.6B
ICON (ICLR)	$24.8B
DiDi Global (DIDIY)	$19.2B
Avantor (AVTR)	$18.8B
Natera (NTRA)	$15.7B
Revvity (RVTY)	$15.6B
Viatris (VTRS)	$14.2B
CochLear (CHEOY)	$12.7B
Solventum (SOLV)	$12.5B
Medpace Holdings (MEDP)	$11.4B
Charles River Laboratories (CRL)	$10.8B
Sonic Healthcare (SKHHY)	$8.8B
Doximity (DOCS)	$7.5B
Bausch + Lomb (BLCO)	$7B
HealthEquity (HQY)	$6.9B
PACS (PACS)	$6.3B
Organon (OGN)	$5.2B
Life Times (LTH)	$5B
Sotera Health (SHC)	$4.7B
Surgery Partners (SGRY)	$4.2B
Concentras Parent (CON)	$2.9B
GoodRx Holdings (GDRX)	$2.7B
BrightSpring Health Services (BTSG)	$2.6B
Ardent Health Partners (ARDT)	$2.6B
Alignment Healthcare (ALHC)	$2.2B
Premier (PINC)	$2B
Ryman Healthcare (RYHTY)	$1.9B
AMN Healthcare Services Inc (AMN)	$1.7B
Agilon Health (AGL)	$1.6B